ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Durham, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Kidney Diseases
Obesity

Diabetes trials near Durham, NC, USA:

Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients (SUNRISE)

The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: TOL-3021 Placebo
Biological: TOL-3021

Phase 2

Tolerion

Chapel Hill, North Carolina, United States and 22 other locations

COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention...

Active, not recruiting
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Other: Intense Education Intervention
Duke University
Duke University

Burlington, North Carolina, United States and 43 other locations

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

Durham, North Carolina, United States and 64 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Wake Forest, North Carolina, United States of America and 24 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

Chapel Hill, North Carolina, United States and 45 other locations

of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...

Enrolling
Diabetes Mellitus, Type 2
Hypercortisolism
Drug: Mifepristone 300 MG [Korlym]
Drug: Placebo for mifepristone

Phase 4

Corcept Therapeutics
Corcept Therapeutics

Chapel Hill, North Carolina, United States and 35 other locations

INHALE-3 is a Phase 4, randomized controlled trial (RCT) that will randomly assign participants ≥18 years of age with type 1 diabetes (T1D) ...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: Afrezza
Biological: Basal Insulin

Phase 4

MannKind
MannKind

Chapel Hill, North Carolina, United States and 18 other locations

preserving beta-cell function and delaying the progression of type 1 diabetes (T1D) in adolescent and adult patients. The safety of ladarixi...

Active, not recruiting
New-onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 3

Dompé
Dompé

Raleigh, North Carolina, United States and 56 other locations

This is a Phase 3 trial of cadisegliatin in participants with Type 1 Diabetes Mellitus....

Enrolling
Diabetes Mellitus, Type 1
Drug: Placebo
Drug: Cadisegliatin 800 mg BID

Phase 3

vTv Therapeutics
vTv Therapeutics

Chapel Hill, North Carolina, United States of America and 14 other locations

The purpose of this study is to understand the effects of the Bluedrop Monitoring System (BMS) on the development of diabetic foot ulcers.Al...

Enrolling
Diabetic Foot
Device: Bluedrop Monitoring Service (BMS)
BlueDop Medical

Durham, North Carolina, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems